Showing results (121-130 of 360) with videos related to

Sort By:
Pageof 36
British Heart Journal|October 1, 1981
Correction of altered noradrenaline reactivity in essential hypertension by indapamideM Grimm, P Weidmann, A Meier, et al.
International Journal of Cancer|March 1, 1996
High-dose therapy/stem cell support: comparison of mice and humansB A Teicher, D Northey, J Yuan, et al.
Carcinogenesis|May 1, 1997
Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidasesH H Schmeiser, E Frei, M Wiessler, et al.
IARC Scientific Publications|January 1, 1987
Could N-nitrosamino phosphates be transport forms of activated N-nitrosamines?N Frank, M Wiessler, B L Pool, et al.
Blut|December 1, 1987
Dihydrofolate reductase-activity in brain tissue. Effect of X-irradiationR Ludwig, E Frei, B Kimmig, et al.
General Physiology and Biophysics|May 7, 2002
Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathyM Stiborová, M Hájek, E Frei, et al.
Carcinogenesis|March 1, 1990
Pharmacokinetics of N-nitrodimethylamine and N-nitromethylamine in the ratM Hassel, E Frei, A J Streeter, et al.
IARC Scientific Publications|January 1, 1987
Investigation into the pharmacodynamics of the carcinogen N-nitrodimethylamineM Hassel, E Frei, H R Scherf, et al.
Biochemical Pharmacology|January 5, 2002
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adductsM Stiborová, C A Bieler, M Wiessler, et al.
General Physiology and Biophysics|January 5, 2002
Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formationM Stiborová, H H Schmeiser, A Breuer, et al.
Pageof 36